Iodine-123 metaiodobenzylguanidine (I-123 MIBG)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Iodine-123 metaiodobenzylguanidine (I-123 MIBG), covering 2017-04-26 to 2017-04-26. Get the full timeline:
Most recent: Clinical Trial Update: Study Dosed With (123I-mIBG) for Identifying Subjects With Heart Failure Who Will Experience an Adverse Cardiac Event